Merck receives European approval for new fertility treatment

Merck & Co has received the European Commission (EC) approval for Elonva (corifollitropin alfa injec

With the EC approval, Merck also receives marketing authorization for Elonva with unified labeling valid in all the EU member states.

Elonva is a sustained follicle stimulant capable of initiating and sustaining multiple follicular growth for an entire week. The company claims that a single subcutaneous injection of the recommended dose of Elonva may replace the first seven injections of any conventional daily recombinant follicle stimulating hormone (rFSH) preparation in a COS treatment cycle.

Mirjam Mol-Arts, senior vice president of Merck Research Laboratories, said: "The European approval of Elonva is a positive step towards reducing the burden of injections for women experiencing difficulty conceiving. Merck is proud of the company's women's health portfolio and is committed to providing effective patient-focused fertility treatments."

The phase III development program for Elonva included the Engage trial, the largest double-blind fertility agent trial in IVF performed to date. In the Engage trial, the ongoing pregnancy rate (the primary endpoint) obtained in the Elonva treatment arm (38.9 per cent per started cycle) was similar to that achieved in patients receiving a daily dose of rFSH (38.1 per cent per started cycle).

Show Hide image

We're hiring! Join the New Statesman as an editorial assistant

The NS is looking for a new recruit.

The New Statesman is hiring an editorial assistant, who will work across the website and magazine to help the office run smoothly. The ideal candidate will have excellent language skills, a passion for journalism, and the ability to work quickly and confidently under pressure.

The job is a broad one – you will need to understand the requirements of both halves of the magazine (politics and culture) as well as having an interest in the technical requirements of magazine and website production. Experience with podcasts and social media would be helpful.

The right person will have omnivorous reading habits and the ability to assimilate new topics at speed. You will be expected to help out with administration tasks around the office, so you must be willing to take direction and get involved with unglamorous tasks. There will be opportunities to write, but this will not form the main part of the job. (Our current editorial assistant is now moving on to a writing post.)

This is a full-time paid job, which would suit a recent graduate or someone who is looking for an entry into journalism. On the job training and help with career development will be offered.

Please apply with an email to Stephen Bush (Stephen. Bush @ with the subject line ‘Editorial Assistant application’.  

In your covering letter, please include a 300-word analysis of the strengths and weaknesses of the New Statesman. Please also include 500 words on what you consider to be the most interesting trend in British politics, and your CV as a Word document. 

The deadline for applications is noon on Monday 12th October.